Large-Cap
Nvidia Invests $2 Billion in CoreWeave to Scale “AI Factories” for the Next Wave of Demand
The deal deepens a strategic partnership as CoreWeave targets 5 gigawatts of AI data center capacity by 2030 Nvidia (NVDA)...
IonQ to Buy SkyWater in $1.8B Deal, Bringing Quantum Chipmaking In-House
Acquisition strengthens U.S. supply chain control and accelerates plans for next-generation quantum processors Quantum computing company IonQ (IONQ) announced Monday...
AI Is Already Transforming Drug Development—Just Not Where Investors Expected
While “AI-discovered” breakthrough medicines are still emerging, pharma is using AI today to cut costs, speed trials, and reduce regulatory...
U.S. Plans $1.6B Investment in USA Rare Earth to Strengthen Critical Minerals Supply Chain
Government to take a 10% stake as Washington accelerates domestic rare earth and magnet production amid rising security priorities The...
Gold Nears $5,000 as Silver Hits $100 in Historic Precious Metals Rally
Weaker dollar, fiscal concerns, and geopolitical tensions fuel one of the strongest runs since 2020 Precious metals surged to record...
Intel’s Outlook Misses, but Turnaround Hopes Stay Alive
Better-than-feared results and rising AI demand support Intel’s narrative, even as near-term pressure builds on margins. Intel (INTC) shares slid...
Alibaba Prepares IPO Path for T-Head as China Ramps Up the Race to Challenge Nvidia
Restructuring plans signal growing investor appetite for domestic AI accelerators amid Beijing’s push for tech independence. Alibaba (BABA) is taking...
Bitcoin Hits $90,000, Then Retreats as Trump Signals Crypto Legislation Progress
Markets react to regulatory optimism, but analysts warn momentum remains fragile below key technical levels. Bitcoin (BTC) briefly surged to...
Netflix Shifts Warner Bros. Bid to All-Cash Deal, Raising Stakes in Hollywood Takeover Fight
Revised $27.75-per-share offer aims to boost certainty for investors and accelerate a shareholder vote as Paramount pressure grows. Netflix (NFLX)...
GSK to Acquire RAPT Therapeutics for $2.2 Billion, Strengthening Its Immunology Pipeline
Deal delivers global rights to experimental food allergy therapy ozureprubart as GSK pursues growth under new CEO Luke Miels. Britain’s...
